Oliver Cornely
@olivercornely.bsky.social
🎓 MD @Uniklinik Köln @Uni Köln 🇩🇪 | FECMM, Infectious Diseases | 🔬 Clinical Trialist @CECAD | 📚 Top 1% Cited (Clarivate) | 📍 @DZIF Bonn-Cologne | 💡 37K+ Volunteers (DE) | 🌍 525 Sites | 🎥 IDIM (YouTube)
Von Schnelltests bis zu Impfstoffen – klinische Studien sichern Gesundheit und retten Leben. Freiwilligen-Register (v-reg) für freiwillige Teilnahme: v-reg.eu
#Medizin #FreiwilligenRegister #Zukunft
#Medizin #FreiwilligenRegister #Zukunft
February 13, 2026 at 11:44 AM
Von Schnelltests bis zu Impfstoffen – klinische Studien sichern Gesundheit und retten Leben. Freiwilligen-Register (v-reg) für freiwillige Teilnahme: v-reg.eu
#Medizin #FreiwilligenRegister #Zukunft
#Medizin #FreiwilligenRegister #Zukunft
Reposted by Oliver Cornely
Reposted by Oliver Cornely
Minnesota health officials warn of sexually transmitted fungal infection outbreak
State health officials have identified 13 confirmed and 27 suspected cases of Trichophyton mentagrophytes type VII, a fungal skin infection that causes severe ringworm.
www.cidrap.umn.edu/s...
State health officials have identified 13 confirmed and 27 suspected cases of Trichophyton mentagrophytes type VII, a fungal skin infection that causes severe ringworm.
www.cidrap.umn.edu/s...
February 12, 2026 at 10:07 PM
Minnesota health officials warn of sexually transmitted fungal infection outbreak
State health officials have identified 13 confirmed and 27 suspected cases of Trichophyton mentagrophytes type VII, a fungal skin infection that causes severe ringworm.
www.cidrap.umn.edu/s...
State health officials have identified 13 confirmed and 27 suspected cases of Trichophyton mentagrophytes type VII, a fungal skin infection that causes severe ringworm.
www.cidrap.umn.edu/s...
⚠️ Die DGI warnt vor einer Schwächung der #Infektiologie.
Neue Daten zeigen: Adipositas erhöht das Risiko für schwere Infektionen deutlich. Infektiologische Expertise rettet Leben, senkt Komplikationen & Kosten – ihre Streichung wäre ein Rückschritt.
👉 biermann-medizin.de/dgi-warnt-vo...
Neue Daten zeigen: Adipositas erhöht das Risiko für schwere Infektionen deutlich. Infektiologische Expertise rettet Leben, senkt Komplikationen & Kosten – ihre Streichung wäre ein Rückschritt.
👉 biermann-medizin.de/dgi-warnt-vo...
DGI warnt vor Schwächung der Infektionsmedizin
Die DGI warnt vor einer Schwächung der Infektionsmedizin durch eine Streichung der Leistungsgruppe Infektiologie.
biermann-medizin.de
February 12, 2026 at 9:12 AM
⚠️ Die DGI warnt vor einer Schwächung der #Infektiologie.
Neue Daten zeigen: Adipositas erhöht das Risiko für schwere Infektionen deutlich. Infektiologische Expertise rettet Leben, senkt Komplikationen & Kosten – ihre Streichung wäre ein Rückschritt.
👉 biermann-medizin.de/dgi-warnt-vo...
Neue Daten zeigen: Adipositas erhöht das Risiko für schwere Infektionen deutlich. Infektiologische Expertise rettet Leben, senkt Komplikationen & Kosten – ihre Streichung wäre ein Rückschritt.
👉 biermann-medizin.de/dgi-warnt-vo...
I’m speaking at #ISHAMAsia2026 in Kuala Lumpur (Sept 9–12).
Join leading experts in medical mycology for the latest research and clinical insights.
See you in KL!
isham.asia
#MedicalMycology #ThinkFungus
Join leading experts in medical mycology for the latest research and clinical insights.
See you in KL!
isham.asia
#MedicalMycology #ThinkFungus
February 11, 2026 at 7:31 AM
I’m speaking at #ISHAMAsia2026 in Kuala Lumpur (Sept 9–12).
Join leading experts in medical mycology for the latest research and clinical insights.
See you in KL!
isham.asia
#MedicalMycology #ThinkFungus
Join leading experts in medical mycology for the latest research and clinical insights.
See you in KL!
isham.asia
#MedicalMycology #ThinkFungus
🦠📊 RKI veröffentlicht erstmals Resistenzdaten zu Pilzen.
Neue ARS-Daten zeigen Resistenzentwicklungen bei Candida spp. und Aspergillus fumigatus in Deutschland. Ein wichtiger Schritt für Therapie & Surveillance.
🔗 amr.rki.de/Content/Date...
#AMR #Pilzresistenzen #RKI
Neue ARS-Daten zeigen Resistenzentwicklungen bei Candida spp. und Aspergillus fumigatus in Deutschland. Ein wichtiger Schritt für Therapie & Surveillance.
🔗 amr.rki.de/Content/Date...
#AMR #Pilzresistenzen #RKI
AMR - Surveillance
AMR - Surveilance: ARS - Antibiotika-Resistenz-Surveillance: nationales Netzwerk zur Surveillance der Antibiotikaresistenz in Deutschland unter Koordination des Robert Koch-Instituts mit dem Ziel eine...
amr.rki.de
February 10, 2026 at 10:05 AM
🦠📊 RKI veröffentlicht erstmals Resistenzdaten zu Pilzen.
Neue ARS-Daten zeigen Resistenzentwicklungen bei Candida spp. und Aspergillus fumigatus in Deutschland. Ein wichtiger Schritt für Therapie & Surveillance.
🔗 amr.rki.de/Content/Date...
#AMR #Pilzresistenzen #RKI
Neue ARS-Daten zeigen Resistenzentwicklungen bei Candida spp. und Aspergillus fumigatus in Deutschland. Ein wichtiger Schritt für Therapie & Surveillance.
🔗 amr.rki.de/Content/Date...
#AMR #Pilzresistenzen #RKI
Final EU-COVAT-1-AGED results:
Randomized 1st & 2nd mRNA booster trial in adults ≥75 yrs. Full-dose mRNA-1273 showed higher anti-RBD IgG & neutralization vs BNT162b2. Neutralization declined vs all 25 variants at 12 months.
www.sciencedirect.com/science/arti...
#COVID19 #Vaccines #Aging #VACCELERATE
Randomized 1st & 2nd mRNA booster trial in adults ≥75 yrs. Full-dose mRNA-1273 showed higher anti-RBD IgG & neutralization vs BNT162b2. Neutralization declined vs all 25 variants at 12 months.
www.sciencedirect.com/science/arti...
#COVID19 #Vaccines #Aging #VACCELERATE
Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) – final report
To determine long-term immunogenicity and reactogenicity of different SARS-CoV-2 mRNA-vaccines in a population ≥75 years in a randomized trial.Partici…
www.sciencedirect.com
February 9, 2026 at 7:48 AM
Final EU-COVAT-1-AGED results:
Randomized 1st & 2nd mRNA booster trial in adults ≥75 yrs. Full-dose mRNA-1273 showed higher anti-RBD IgG & neutralization vs BNT162b2. Neutralization declined vs all 25 variants at 12 months.
www.sciencedirect.com/science/arti...
#COVID19 #Vaccines #Aging #VACCELERATE
Randomized 1st & 2nd mRNA booster trial in adults ≥75 yrs. Full-dose mRNA-1273 showed higher anti-RBD IgG & neutralization vs BNT162b2. Neutralization declined vs all 25 variants at 12 months.
www.sciencedirect.com/science/arti...
#COVID19 #Vaccines #Aging #VACCELERATE
Honored to host Prof. Ruoyu Li & Prof. Yinggai Song at our ECMM Excellence Center Cologne. From Cologne Cathedral to TRIO lab, insightful discussions & guided tours. Looking forward to future collaborations!
February 6, 2026 at 1:30 PM
Honored to host Prof. Ruoyu Li & Prof. Yinggai Song at our ECMM Excellence Center Cologne. From Cologne Cathedral to TRIO lab, insightful discussions & guided tours. Looking forward to future collaborations!
At PRISMA Congress, @salmantongarcia.bsky.social presents "The evolving challenge of fungal resistance", highlighting the latest developments and emerging clinical challenges in antifungal resistance. #PRISMA2026 #FungalResistance
February 6, 2026 at 10:06 AM
At PRISMA Congress, @salmantongarcia.bsky.social presents "The evolving challenge of fungal resistance", highlighting the latest developments and emerging clinical challenges in antifungal resistance. #PRISMA2026 #FungalResistance
🎥 New video!
Prof. @franbridi.bsky.social introduces rezafungin, a next-generation echinocandin, covering MOA, PK profile & clinical potential in invasive fungal infections.
👉 Watch now: youtu.be/4-rKQjsppOg
More videos coming soon!
Prof. @franbridi.bsky.social introduces rezafungin, a next-generation echinocandin, covering MOA, PK profile & clinical potential in invasive fungal infections.
👉 Watch now: youtu.be/4-rKQjsppOg
More videos coming soon!
Rezafungin: A New Echinocandin for Invasive Fungal Infections
YouTube video by IDIM IDIM
youtu.be
February 5, 2026 at 11:26 AM
🎥 New video!
Prof. @franbridi.bsky.social introduces rezafungin, a next-generation echinocandin, covering MOA, PK profile & clinical potential in invasive fungal infections.
👉 Watch now: youtu.be/4-rKQjsppOg
More videos coming soon!
Prof. @franbridi.bsky.social introduces rezafungin, a next-generation echinocandin, covering MOA, PK profile & clinical potential in invasive fungal infections.
👉 Watch now: youtu.be/4-rKQjsppOg
More videos coming soon!
New episode of MedFacts with Prof. Schmitt 🎥
Clear, science-based insights into adult vaccination, based on the Vaccitutor Course. Short, accessible, and evidence-based vaccine facts.
Watch now ▶️ www.youtube.com/shorts/uTy3t...
Clear, science-based insights into adult vaccination, based on the Vaccitutor Course. Short, accessible, and evidence-based vaccine facts.
Watch now ▶️ www.youtube.com/shorts/uTy3t...
MedFacts with Prof. Schmitt: Adult Vaccination
YouTube video by IDIM IDIM
www.youtube.com
February 4, 2026 at 10:42 AM
New episode of MedFacts with Prof. Schmitt 🎥
Clear, science-based insights into adult vaccination, based on the Vaccitutor Course. Short, accessible, and evidence-based vaccine facts.
Watch now ▶️ www.youtube.com/shorts/uTy3t...
Clear, science-based insights into adult vaccination, based on the Vaccitutor Course. Short, accessible, and evidence-based vaccine facts.
Watch now ▶️ www.youtube.com/shorts/uTy3t...
Last week’s #READI General Assembly in Madrid ❄️
Dr. Kerstin Albus and Dr. Johanna Brustkern represented WP5 Clinical Sites #Capability Building, strengthening #clinicaltrial site competencies across Europe to support inclusive, multi-centre research. Great energy – READI is in motion 🚀
Dr. Kerstin Albus and Dr. Johanna Brustkern represented WP5 Clinical Sites #Capability Building, strengthening #clinicaltrial site competencies across Europe to support inclusive, multi-centre research. Great energy – READI is in motion 🚀
February 4, 2026 at 9:50 AM
Last week’s #READI General Assembly in Madrid ❄️
Dr. Kerstin Albus and Dr. Johanna Brustkern represented WP5 Clinical Sites #Capability Building, strengthening #clinicaltrial site competencies across Europe to support inclusive, multi-centre research. Great energy – READI is in motion 🚀
Dr. Kerstin Albus and Dr. Johanna Brustkern represented WP5 Clinical Sites #Capability Building, strengthening #clinicaltrial site competencies across Europe to support inclusive, multi-centre research. Great energy – READI is in motion 🚀
Reposted by Oliver Cornely
Mark your calendars for the #AMR Science-Policy Forum at Education Friday during #ESCMIDGlobal2026. Open to all congress attendees, the programme features unique sessions designed to foster interactive, solution-oriented discussions. More info:
https://ow.ly/wIGk50Y60Ml
#IDSky #clinmicro
https://ow.ly/wIGk50Y60Ml
#IDSky #clinmicro
February 3, 2026 at 1:00 PM
Mark your calendars for the #AMR Science-Policy Forum at Education Friday during #ESCMIDGlobal2026. Open to all congress attendees, the programme features unique sessions designed to foster interactive, solution-oriented discussions. More info:
https://ow.ly/wIGk50Y60Ml
#IDSky #clinmicro
https://ow.ly/wIGk50Y60Ml
#IDSky #clinmicro
Honored to feature Prof. Arunaloke Chakrabarti in the ISHAM Pioneers in Mycology series. A deep dive into his impact on medical mycology, global challenges, and the future of fungal disease research. Watch the interview: www.isham.org/about-isham/...
February 3, 2026 at 12:09 PM
Honored to feature Prof. Arunaloke Chakrabarti in the ISHAM Pioneers in Mycology series. A deep dive into his impact on medical mycology, global challenges, and the future of fungal disease research. Watch the interview: www.isham.org/about-isham/...
New AGIHO guideline update on G-CSF prophylaxis in adult cancer patients! Evidence-based recommendations incl. immunotherapy settings, biosimilars & risk stratification to support clinical decision-making.
🔗 pubmed.ncbi.nlm.nih.gov/41570611/
@rosannesprute.bsky.social
#Oncology #Guidelines
🔗 pubmed.ncbi.nlm.nih.gov/41570611/
@rosannesprute.bsky.social
#Oncology #Guidelines
Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer - PubMed
Comprehensive literature search and expert panel consensus confirm most of the key recommendations of 2014. New recommendations on the use of G-CSF in immunotherapy settings provide insight and support for day-by-day clinical decision making in the care of patients with cancer.
pubmed.ncbi.nlm.nih.gov
February 3, 2026 at 10:02 AM
New AGIHO guideline update on G-CSF prophylaxis in adult cancer patients! Evidence-based recommendations incl. immunotherapy settings, biosimilars & risk stratification to support clinical decision-making.
🔗 pubmed.ncbi.nlm.nih.gov/41570611/
@rosannesprute.bsky.social
#Oncology #Guidelines
🔗 pubmed.ncbi.nlm.nih.gov/41570611/
@rosannesprute.bsky.social
#Oncology #Guidelines
Room 007. I can hear Gladys Knight singing License to Kill ... Fungi. Always wanted to know who 006 and 008 are - we’ll find out. Meanwhile in Leuven: ESCMID Antifungal Stewardship, led by Riina Richardson.
👉 www.escmid.org/education/co...
👉 www.escmid.org/education/co...
January 30, 2026 at 6:58 AM
Room 007. I can hear Gladys Knight singing License to Kill ... Fungi. Always wanted to know who 006 and 008 are - we’ll find out. Meanwhile in Leuven: ESCMID Antifungal Stewardship, led by Riina Richardson.
👉 www.escmid.org/education/co...
👉 www.escmid.org/education/co...
Die 4. Auflage von „Internistische Intensivmedizin“ ist da: systematisch, leitlinienorientiert und praxisnah – ideal für Klinikalltag und Prüfungsvorbereitung.
📖 Mehr hier: link.springer.com/book/10.1007...
#Intensivmedizin #Klinik #Medizin
📖 Mehr hier: link.springer.com/book/10.1007...
#Intensivmedizin #Klinik #Medizin
Repetitorium Internistische Intensivmedizin
In diesem Werk findet sich das gesamte Spektrum der internistischen Intensivmedizin systematisch, leitlinienorientiert und praxisnah dargestellt.
link.springer.com
January 29, 2026 at 11:41 AM
Die 4. Auflage von „Internistische Intensivmedizin“ ist da: systematisch, leitlinienorientiert und praxisnah – ideal für Klinikalltag und Prüfungsvorbereitung.
📖 Mehr hier: link.springer.com/book/10.1007...
#Intensivmedizin #Klinik #Medizin
📖 Mehr hier: link.springer.com/book/10.1007...
#Intensivmedizin #Klinik #Medizin
Kerstin Albus & Johanna Brustkern from our Cologne team are in Madrid ❄️ for Day 1 of the #READI General Assembly – driving clinical research that truly reflects all populations and promotes equity, diversity, and inclusion.
#READI #GlobalHealth #HealthEquity #ImplementationScience
#READI #GlobalHealth #HealthEquity #ImplementationScience
January 29, 2026 at 11:08 AM
Kerstin Albus & Johanna Brustkern from our Cologne team are in Madrid ❄️ for Day 1 of the #READI General Assembly – driving clinical research that truly reflects all populations and promotes equity, diversity, and inclusion.
#READI #GlobalHealth #HealthEquity #ImplementationScience
#READI #GlobalHealth #HealthEquity #ImplementationScience
New 2025 evidence-based guideline from AGIHO/DGHO on prevention, diagnosis & management of community-acquired respiratory viruses including COVID-19 in cancer patients. Read here: pubmed.ncbi.nlm.nih.gov/41563477/
Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO) - PubMed
Community-acquired respiratory viruses (CARV), such as influenza-, parainfluenza- or respiratory syncytial virus, pose a significant threat to immunocompromised patients with cancer. Following the COVID-19 pandemic, SARS-CoV-2 has now joined the ranks of endemic respiratory viruses and continues to …
pubmed.ncbi.nlm.nih.gov
January 28, 2026 at 11:08 AM
New 2025 evidence-based guideline from AGIHO/DGHO on prevention, diagnosis & management of community-acquired respiratory viruses including COVID-19 in cancer patients. Read here: pubmed.ncbi.nlm.nih.gov/41563477/
RSV poses high risk in adults with hematological malignancies. Study highlights the urgent need for higher vaccination coverage, faster diagnostics & improved therapies to reduce hospitalizations, secondary infections and mortality. Read: onlinelibrary.wiley.com/doi/10.1002/...
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry
Click on the article title to read more.
onlinelibrary.wiley.com
January 27, 2026 at 10:18 AM
RSV poses high risk in adults with hematological malignancies. Study highlights the urgent need for higher vaccination coverage, faster diagnostics & improved therapies to reduce hospitalizations, secondary infections and mortality. Read: onlinelibrary.wiley.com/doi/10.1002/...
🎉 Wir freuen uns riesig mit dir, @rosannesprute.bsky.social !
Herzlichen Glückwunsch zur Fachärztin für Innere Medizin – eine großartige Leistung, die viel Einsatz und Ausdauer zeigt. Schön, dich im Team zu haben! ✨
Herzlichen Glückwunsch zur Fachärztin für Innere Medizin – eine großartige Leistung, die viel Einsatz und Ausdauer zeigt. Schön, dich im Team zu haben! ✨
January 27, 2026 at 8:27 AM
🎉 Wir freuen uns riesig mit dir, @rosannesprute.bsky.social !
Herzlichen Glückwunsch zur Fachärztin für Innere Medizin – eine großartige Leistung, die viel Einsatz und Ausdauer zeigt. Schön, dich im Team zu haben! ✨
Herzlichen Glückwunsch zur Fachärztin für Innere Medizin – eine großartige Leistung, die viel Einsatz und Ausdauer zeigt. Schön, dich im Team zu haben! ✨
India faced a deadly surge of “black fungus” (#mucormycosis) during COVID-19. Steroids, diabetes & immune suppression fueled cases of this rare but often fatal fungal infection.
👉 www.science.org/content/arti...
#Mycology #InfectiousDiseases #COVID19
👉 www.science.org/content/arti...
#Mycology #InfectiousDiseases #COVID19
Why a fatal ‘black fungus’ struck India during the COVID-19 pandemic
Mucormycosis may be triggered by low levels of albumin, the most common blood protein
www.science.org
January 26, 2026 at 11:29 AM
India faced a deadly surge of “black fungus” (#mucormycosis) during COVID-19. Steroids, diabetes & immune suppression fueled cases of this rare but often fatal fungal infection.
👉 www.science.org/content/arti...
#Mycology #InfectiousDiseases #COVID19
👉 www.science.org/content/arti...
#Mycology #InfectiousDiseases #COVID19
🦠 Neues zu #Candida & #Aspergillus!
GiDi LIVE Webinar-Aufzeichnung zu #Rezafungin & moderner Mykologie-Diagnostik.
Registrierung dauert nur Sekunden.
👉 giftigerdienstag.at/rezafungin-e...
GiDi LIVE Webinar-Aufzeichnung zu #Rezafungin & moderner Mykologie-Diagnostik.
Registrierung dauert nur Sekunden.
👉 giftigerdienstag.at/rezafungin-e...
Rezafungin – Ein neues Echinocandin für Hefe & Schimmel - Giftiger Dienstag
Rezafungin, der neueste Echinocandinvertreter. Gezielt eingesetzt, klug entschieden, bessere Ergebnisse. Candida auris. Pneumocystis jirovecciii. Aspergillus & Candida.
giftigerdienstag.at
January 26, 2026 at 11:12 AM
🦠 Neues zu #Candida & #Aspergillus!
GiDi LIVE Webinar-Aufzeichnung zu #Rezafungin & moderner Mykologie-Diagnostik.
Registrierung dauert nur Sekunden.
👉 giftigerdienstag.at/rezafungin-e...
GiDi LIVE Webinar-Aufzeichnung zu #Rezafungin & moderner Mykologie-Diagnostik.
Registrierung dauert nur Sekunden.
👉 giftigerdienstag.at/rezafungin-e...
📣 Save the Date: Kölner Antibiotika-Tag am 31.01.!
Erfahren Sie mehr über aktuelle Entwicklungen in der Antibiotikaforschung und spannende Beiträge aus Klinik & Wissenschaft. 👉 www.uk-koeln.de/fileadmin/us...
Erfahren Sie mehr über aktuelle Entwicklungen in der Antibiotikaforschung und spannende Beiträge aus Klinik & Wissenschaft. 👉 www.uk-koeln.de/fileadmin/us...
January 23, 2026 at 11:47 AM
📣 Save the Date: Kölner Antibiotika-Tag am 31.01.!
Erfahren Sie mehr über aktuelle Entwicklungen in der Antibiotikaforschung und spannende Beiträge aus Klinik & Wissenschaft. 👉 www.uk-koeln.de/fileadmin/us...
Erfahren Sie mehr über aktuelle Entwicklungen in der Antibiotikaforschung und spannende Beiträge aus Klinik & Wissenschaft. 👉 www.uk-koeln.de/fileadmin/us...
Join the EFISG webinar “Women in Science – Past, Present, and Future” 🧬
📅 11 Feb 2026 | 🕕 18:00 CET
🎓 Inspiring speakers & discussions on women’s careers in science.
👉 Register: us06web.zoom.us/webinar/regi...
@salmantongarcia.bsky.social
#EFISG_FREE_WEBINAR
📅 11 Feb 2026 | 🕕 18:00 CET
🎓 Inspiring speakers & discussions on women’s careers in science.
👉 Register: us06web.zoom.us/webinar/regi...
@salmantongarcia.bsky.social
#EFISG_FREE_WEBINAR
January 23, 2026 at 9:12 AM
Join the EFISG webinar “Women in Science – Past, Present, and Future” 🧬
📅 11 Feb 2026 | 🕕 18:00 CET
🎓 Inspiring speakers & discussions on women’s careers in science.
👉 Register: us06web.zoom.us/webinar/regi...
@salmantongarcia.bsky.social
#EFISG_FREE_WEBINAR
📅 11 Feb 2026 | 🕕 18:00 CET
🎓 Inspiring speakers & discussions on women’s careers in science.
👉 Register: us06web.zoom.us/webinar/regi...
@salmantongarcia.bsky.social
#EFISG_FREE_WEBINAR